Stay updated on Daratumumab in Waldenström Macroglobulinemia Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.

Latest updates to the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page
- Check2 days agoChange DetectedThe revision tag on the page updated from v3.6.2 to v3.6.3, indicating a minor update to the page template or metadata. It does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check9 days agoChange DetectedThe revision tag on the study page was updated from v3.6.0 to v3.6.2. This reflects a recent page update without substantive changes to the study details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status updated to indicate the study is no longer looking for participants, signaling that enrollment has closed. Added navigation and help items—'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study'—along with a page revision note 'Revision: v3.6.0' to reflect updates to the study record layout.SummaryDifference0.4%

- Check30 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a minor page version update. No study content or data appears to be changed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows revision v3.5.4, replacing the previous v3.5.3, indicating a minor update to the page’s metadata.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page shows a revision tag that updates the version from v3.5.2 to v3.5.3, representing a minor update to the page; the core study details and layout remain the same.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in Waldenström Macroglobulinemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.